CREATION AND PHARMACOTECHNOLOGICAL INVESTIGATIONS OF INNOVATIVE DOSAGE FORMS OF MEXIDOL

CREATION AND PHARMACOTECHNOLOGICAL INVESTIGATIONS OF INNOVATIVE DOSAGE FORMS OF MEXIDOL

The present study is devoted to the creation and study of transdermal dosage forms with mexidol and experimental substantiation of their therapeutic efficacy. The original technological scheme of production of one of the most popular structures transdermal - transdermal patches with mexidol. Selecte...

Full description

Saved in:

Bibliographic Details
Main Authors:	E. F. Stepanova, S. O. Losenkova, Yu. A. Morozov
Format:	Article
Language:	Russian
Published:	LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2019-01-01
Series:	Разработка и регистрация лекарственных средств
Subjects:	mexidol transdermal patches percutaneous transport biopharmaceutical studies in vitro excipients
Online Access:	https://www.pharmjournal.ru/jour/article/view/631
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

DEVELOPMENT AND RESEARCH OF DOSAGE FORMS WITH CETIRIZI
by: J. Magomedova, et al.
Published: (2022-08-01)

OXIDATIVE STRESS AND ITS PHARMACOLOGICAL CORRECTION by MEXIDOL IN TRAUMATIC BRAIN INJURY
by: N. V. Govorova
Published: (2016-02-01)

Glutathione content in erythrocytes and bone marrow of animals in mexidol use under the conditions of acute stress
by: N. O. Vlasenko
Published: (2013-06-01)

Comparative chemoreactome analysis of mexidol
by: I. J. Torshin, et al.
Published: (2016-11-01)

COMPARATIVE ANTICONVULSANT AND ANTIHYPOXIC EFFECTS OF ASTROKS AND MEXIDOL IN INJECTABLE FORM AND 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE SUCCINATE SUBSTANCE
by: T. A. Voronina, et al.
Published: (2016-06-01)

Defining Structure‐Function Relationships of Amphiphilic Excipients Enables Rational Design of Ultra‐Stable Biopharmaceuticals
by: Alexander N. Prossnitz, et al.
Published: (2025-02-01)

Ultrastructure of thyrocytes, assessment of their functional state after prolonged exposure to sodium benzoate and simulation of bone fractures and justification for the effectiveness of mexidol and selenase
by: Vitalii N. Morozov
Published: (2024-09-01)

Effect of the combination of mexidol and diclofenac sodium on exudative inflammation in rats after ten-day preventive oral administration
by: E. A. Ivanova, et al.
Published: (2022-05-01)

Comparative analysis of the pharmacokinetic parameters of transdermal and injectable forms of nicotinamide
by: V. A. Ryzhikova, et al.
Published: (2023-07-01)

Effect of multiple-dose regimens of cyclooxygenase inhibitors and their combinations with mexidol on behavior in mature rats
by: E. A. Ivanova, et al.
Published: (2023-05-01)

The Use of Plant-Derived Biomaterials as Drug Formulation Excipients: An Application of Biomimetics in Dosage Form Development
by: Omobolanle Ayoyinka Omoteso, et al.
Published: (2024-05-01)

Transdermal patches: Design and current approaches to painless drug delivery
by: Al Hanbali Othman A., et al.
Published: (2019-06-01)

APPROACHES TO THE SELECTION OF EXCIPIENTS FOR DENTAL GEL WITH CETYLPYRIDINIUM CHLORIDE
by: E. Yu. Zagorulko, et al.
Published: (2021-06-01)

The Activity Test of Transdermal Patch Formulations From Ethanol Extract of Java Chili (Piper Retrofractum Vahl.) as an Analgesic in Male Mice
by: Annisa Luthfiyyah, et al.
Published: (2025-06-01)

Pharmacological activity of polyphenolic connections in the conditions of alcoholic intoxication
by: A. V. Krikova, et al.
Published: (2011-10-01)

A Hierarchical Short Microneedle-Cupping Dual-Amplified Patch Enables Accelerated, Uniform, Pain-Free Transdermal Delivery of Extracellular Vesicles
by: Minwoo Song, et al.
Published: (2025-07-01)

Drug distribution in dorsal root ganglion after peripheral application of Lidocaine patch
by: Geng Xu, et al.
Published: (2025-05-01)

CHARACTERIZATION AND PHARMACEUTICAL EVALUATION OF DAUCUS CAROTA PECTIN AS A SUSPENDING AGENT IN ORAL DOSAGE FORMS
by: Frederick William Akuffo Owusu, et al.
Published: (2024-03-01)

Cardioprotective activity and screening of N-substituted of quinazolin-4(3Н)-ones
by: O. V. Dzhyhaliuk, et al.
Published: (2019-02-01)

Effective tissue antiischemic therapy of etiologically various vascular diseases of the brain
by: A. L. Vertkin
Published: (2016-04-01)

Characterization of key ingredients of essential oil-loaded biopolymer-based transdermal patches
by: Prasamsha Panta, et al.
Published: (2025-05-01)

Transdermal delivery of tolterodine tartrate for overactive bladder treatment: In vitro and in vivo evaluation
by: Rajabalaya Rajan, et al.
Published: (2017-09-01)

Association between treatment response and dose of blonanserin transdermal patch in patients with acute schizophrenia: A post hoc cluster analysis based on baseline psychiatric symptoms
by: Yoshiteru Takekita, et al.
Published: (2024-12-01)

Treatment of vertigo in elderly patients with chronic cerebrovascular disease
by: S. N. Duma
Published: (2018-04-01)

Biopharmaceutical aspects of the development of transdermal forms of Lisinopril dihydrate
by: Shyteyeva Tatyana, et al.
Published: (2024-09-01)

The potential of microneedle platforms in addressing pediatric drug delivery challenges: perspectives of healthcare professionals and parents
by: Heba Y. Raslan, et al.
Published: (2025-07-01)

Transdermal delivery of traditional Chinese medicine patch vs. NSAIDs patch for alleviating inflammation and relieving pain for early-stage knee osteoarthritis: a retrospective case control study
by: Shoufeng Wang, et al.
Published: (2025-04-01)

Clinicians’ Perspectives of Twice-Weekly Rivastigmine Patches for Alzheimer’s Disease Treatment in Spain: The VIITAL 2S Study
by: Piñol Ripoll G, et al.
Published: (2025-04-01)

A systematic review of commercial high concentration antibody drug products approved in the US: formulation composition, dosage form design and primary packaging considerations
by: Indrajit Ghosh, et al.
Published: (2023-12-01)

Transdermal microneedle patch for antioxidants release
by: Samuel Mugo, et al.
Published: (2025-03-01)

The effects of alpha-lipoic acid transdermal patch for local subcutaneous fat reduction: A randomized, placebo-controlled, clinical trial in overweight volunteers
by: Kanidta Sooklert, et al.
Published: (2024-12-01)

Impact of transdermal buprenorphine patch combined with celecoxib on improving shoulder pain and function of patients with primary adhesive shoulder capsulitis
by: Qingbang Xu, et al.
Published: (2024-11-01)

Green synthesis of Colocasia esculenta-based silver nanoparticles: characterization and transdermal delivery for anti-inflammatory applications
by: Xiaobo Wang, et al.
Published: (2025-08-01)

Formulation and characterization of transdermal drug delivery system comprising esomeprazole
by: Sudha Patil, et al.
Published: (2025-01-01)

Photothermal‐Responsive Soluble Microneedle Patches for Meibomian Gland Dysfunction Therapy
by: Fei Yu, et al.
Published: (2025-03-01)

Strategic aspects of staffing industrial biopharmaceutical companies
by: A. S. Glazkova, et al.
Published: (2020-01-01)

Biofunctional Excipients: Their Emerging Role in Overcoming the Inherent Poor Biopharmaceutical Characteristics of Drugs
by: Milad Reda Qelliny, et al.
Published: (2025-05-01)

RANGE AND CHARACTERISTICS TRANSMUCOSAL DOSAGE FORMS
by: N. V. Shestakov, et al.
Published: (2019-01-01)

The investigation of kinetics dissolution of prolonged indapamide drugs in biorelevant media
by: E. Yu. Sannikova, et al.
Published: (2013-03-01)

A review on the role of co-processed excipients in tablet formulations
by: Ankita S. Burande, et al.
Published: (2024-12-01)